Emergent BioSolutions Reports Financial Results for Second Quarter and First …Wall Street Journal (press release)… otlertuzumab and rituximab in relapsed CLL patients; — Announced positive preclinical efficacy and pharmacokinetic data for ES414, a…
Obinutuzumab active in three types of lymphomaHealioThirty-eight patients had undergone prior treatment with rituximab (Rituxan, Genentech/Idec Pharmaceuticals) and 22 were rituximab refractory. Researchers assigned the patients to one of two regimens….
RESEARCH AND MARKETS: Global and Chinese Monoclonal Antibody Industry …4-traders (press release)Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprise, which possessed seven products sold in the market including Avastin, He…
BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 …PR Newswire (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow m…
BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 …MarketWatch (press release)Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow m…
Global & China Monoclonal Antibody Market Analysis and 2017 Forecasts in …PR Web (press release)Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avasti…
Antibody boosts effectiveness of leukemia treatmentTelemanagementResearchers at the University of Texas M.D. Anderson Cancer Center have been treating a group of 202 patients with CLL with standard chemotherapy plus the monoclonal antibody rituximab. T…
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma …7thSpace Interactive (press release)Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy inclu…
Rituximab Therapy Effective For ANCA-Associated VasculitisRedOrbitIn an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxa…
Answers About Rheumatoid Arthritis, Part 3New York TimesThese include small molecules (pills) like methotrexate, leflunomide, tofacitinib and injectable or infusable biologic therapies like abatacept, adalimumab, certolizumab, etanercept, golimumab, ri…